Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multi-center Sample Collection Study for Evaluating the Analytical Equivalency of Serum and Whole Blood Samples Run on the MeMed Key® Platform ("Perseverance" Study)

NCT05439551 is registered in ClinicalTrials.gov with MeMed Diagnostics Ltd. as lead sponsor.

NCT NCT05439551
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05439551 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multi-center Sample Collection Study for Evaluating the Analytical Equivalency of Serum and Whole Blood Samples Run on the MeMed Key® Platform ("Perseverance" Study)
Lead sponsor
MeMed Diagnostics Ltd.
Phase
Observational
Overall status
Completed
Start date
February 11, 2022
Completion date
September 29, 2023
Enrollment
215 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

acute infection